Orlando Health Cancer Institute — Orlando, Florida

Orlando Health Cancer Institute is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Orlando Health Cancer Institute has participated in 160 clinical trials with 106 currently active.

Therapeutic areas: Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer.

Sponsors: Syros Pharmaceuticals, Pfizer, Eikon Therapeutics.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Orlando Health Cancer Institute?

Orlando Health Cancer Institute has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Orlando Health Cancer Institute conducted?

Orlando Health Cancer Institute has 160 clinical trials on record, with 106 currently active. Their work covers Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer.

Is Orlando Health Cancer Institute accredited by Crixeo Health?

Orlando Health Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Orlando Health Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.